NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies said on Friday that it has received notification from the Nasdaq that its stock faces delisting for failing to meet the exchange's $1 minimum bid price requirement.
NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies said on Friday that it has received notification from the Nasdaq that its stock faces delisting for failing to meet the exchange's $1 minimum bid price requirement.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.